Evidence map›Paper›PMID 21973019›Full record

ArticleEpilepsia2011

Inhibition of the mammalian target of rapamycin blocks epilepsy progression in NS-Pten conditional knockout mice.

C Nicole Sunnen, Amy L Brewster, Joaquin N Lugo, Fabiola Vanegas, Eric Turcios, Shivani Mukhi, Deena Parghi, Gabriella D'Arcangelo, Anne E Anderson

Open access · greenAbstract read
In one paragraph

Article in Epilepsia, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 122 citations in OpenAlex.

  1. Article
  2. Cell-Intrinsic Regulation of Epilepsy-Associated Pathology by mTORC1 and mTORC2.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. PTEN DELETION IN THE ADULT DENTATE GYRUS INDUCES EPILEPSY.bioRxiv : the preprint server for biology · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. mTORC2 Inhibition Improves Morphological Effects of PTEN Loss, But Does Not Correct Synaptic Dysfunction or Prevent Seizures.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  17. Seizures and epilepsy in patients with ischaemic stroke.Neurological research and practice · 2021
    Review
  18. Article
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

C Nicole SunnenThe Cain Foundation Laboratories and The Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, Texas 77030, USA.
Amy L Brewster
Joaquin N Lugo
Fabiola Vanegas
Eric Turcios
Shivani Mukhi
Deena Parghi
Gabriella D'Arcangelo
Anne E Anderson
Texas Children's Hospital · USNeurological Research Institute · US

Funding

UNDERSTANDING FXTAS AMONG MALES WITH THE FMR1 PREMUTATIONP30HD024064 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI WHITE, LISA D · 1988 to 2013
$29.4M
Mutidisciplinary Training;Brain Disorders &DevelopmentT32NS043124 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI SWANN, JOHN WILLIAM · 2002 to 2021
$4.6M
The MAPK Cascade in EpilepsyR01NS039943 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI ANDERSON, ANNE E · 2001 to 2011
$2.9M
Function of Reelin in cortical developmentR01NS042616 · NINDS · RUTGERS, THE STATE UNIV OF N.J. · PI D'ARCANGELO, GABRIELLA · 2003 to 2007
$1.8M
Ion Channel Regulation of Excitability in Immature BrainR01NS049427 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI ANDERSON, ANNE E · 2006 to 2010
$1.7M
Mechanisms of regulation of excitability in immature CNSF32NS056664 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI LUGO, JOAQUIN N · 2008 to 2010
$145k
NICHD NIH HHS P30 HD024064NICHD NIH HHS P30HD 024064NINDS NIH HHS F32 NS056664NINDS NIH HHS F32NS 56664NINDS NIH HHS R01 NS039943NINDS NIH HHS R01 NS042616NINDS NIH HHS R01NS 042616NINDS NIH HHS R01 NS049427NINDS NIH HHS R01NS 39943NINDS NIH HHS T32 NS043124NINDS NIH HHS T32NS 43124PHS HHS 49427
6 · The paper itself

Abstract

purposeIncreased activity of mTOR Complex 1 (mTORC1) has been demonstrated in cortical dysplasia and tuberous sclerosis complex, as well as in animal models of epilepsy. Recent studies in such models revealed that inhibiting mTORC1 with rapamycin effectively suppressed seizure activity. However, seizures can recur after treatment cessation, and continuous rapamycin exposure can adversely affect animal growth and health. Here, we evaluated the efficacy of an intermittent rapamycin treatment protocol on epilepsy progression using neuron subset-specific-Pten (NS-Pten) conditional knockout mice.

methodsNS-Pten knockouts were treated with a single course of rapamycin during postnatal weeks 4 and 5, or intermittently over a period of 5 months. Epileptiform activity was monitored using video-electroencephalography (EEG) recordings, and mossy fiber sprouting was evaluated using Timm staining. Survival and body weight were assessed in parallel. KEY

findingsNS-Pten knockouts treated with a single course of rapamycin had recurrence of epilepsy 4-7 weeks after treatment ended. In contrast, epileptiform activity remained suppressed, and survival increased if knockout mice received additional rapamycin during weeks 10-11 and 16-17. Aberrant mossy fiber sprouting, present by 4 weeks of age and progressing in parallel with epileptiform activity, was also blocked by rapamycin. SIGNIFICANCE: These findings demonstrate that a single course of rapamycin treatment suppresses epileptiform activity and mossy fiber sprouting for several weeks before epilepsy recurs. However, additional intermittent treatments with rapamycin prevented this recurrence and enhanced survival without compromising growth. Therefore, these studies add to the growing body of evidence implicating an important role for mTORC1 signaling in epilepsy.

Indexed as

AnimalsDentate GyrusDisease ProgressionElectroencephalographyEpilepsyFemaleMaleMiceNerve FibersPTEN PhosphohydrolaseSirolimusTOR Serine-Threonine KinasesPTEN PhosphohydrolasePten protein, mouseSirolimusTOR Serine-Threonine Kinases

Identifiers

PMID21973019
PMCPMC3204180
OpenAlexW1911060901

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.